Filing Flows › LifeStance Health Group (LFST) › Q3 2025
LifeStance Health Group (LFST) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
LifeStance Health Group (LFST) reported revenue of $364M for the third quarter 2025 (Q3 2025), +16% from a year earlier and +5% from the quarter before. Operating margin was 2.0%, net earnings $1.1M (0.3% of revenue).
LifeStance Health Group, Q3 2025: revenue $364M (+16% year over year), operating margin 2.0%, net earnings $1.1M, operating cash flow $27.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $364M | +5% | +16% |
| Operating profit | $7.4M | — | 158× |
| Net earnings | $1.1M | — | — |
| Operating cash flow | $27.3M | -58% | +20% |
| Free cash flow | $17.0M | -70% | -4% |
What changed
Revenue was $363.8M in Q3 2025, up 16% year over year and up 5% from the previous quarter.
Operating profit was $7.4M, a 2.0% margin (up 2.0 points year over year). Of the extra revenue versus a year earlier, 14% reached operating profit, above the 0% margin then. Total costs grew 14% against revenue growth of 16%. The fastest-growing cost line was Other operating costs (+15%). Net earnings were $1.1M. The effective tax rate was 76.4%.
Operating cash flow was $27.3M (up 20% year over year), 2534% of net earnings. Non-cash charges added back $10.3M of depreciation and amortization and $18.3M of share-based compensation. Working capital and other items used $2.4M. Capital expenditures of $10.3M left free cash flow of $17.0M.
Questions
What was LifeStance Health Group's revenue in the third quarter 2025?
LifeStance Health Group (LFST) reported revenue of $364M for the third quarter 2025 (Q3 2025), +16% from a year earlier and +5% from the quarter before.
Was LifeStance Health Group profitable in the third quarter 2025?
Operating profit was $7.4M (2.0% of revenue) and net earnings $1.1M.